CYTOKINETICS INC
CYTK
80 insider filings · Latest: Aug 10, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 1 10:54 PM | Edward M. Kaye MDDirector | Sale | 2,933 | $76.09 | $223.2K | 10,283(D) | View → |
| Jun 1, 2026 | Jun 1 10:51 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 15,000 | $74.08 | $1.1M | 58,555(D) | View → |
| Jun 1, 2026 | Jun 1 10:49 PM | Lynne B ParshallDirector | Sale | 5,000 | $74.08 | $370.4K | 15,784(D) | View → |
| Jun 1, 2026 | Jun 1 8:17 PM | EDWARD KAYE | Proposed Sale | 2,933 | $76.76 | $225.1K | — | View → |
| May 27, 2026 | May 28 8:21 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $77.21 | $579.1K | 392,830(D) | View → |
| May 19, 2026 | May 20 8:00 PM | Fady Ibraham MalikEVP Research & Development | Sale | 3,500 | $75.69 | $264.9K | 153,902(D) | View → |
| May 14, 2026 | May 14 8:26 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $77.92 | $584.4K | 400,330(D) | View → |
| May 5, 2026 | May 5 9:35 PM | Fady Ibraham MalikEVP Research & Development | Sale | 3,500 | $77.37 | $270.8K | 153,902(D) | View → |
| May 5, 2026 | May 5 8:33 PM | WENDELL WIERENGA | Proposed Sale | 4,032 | $66.05 | $266.3K | — | View → |
| May 5, 2026 | May 5 8:31 PM | JOHN HENDERSON | Proposed Sale | 20,000 | $66.05 | $1.3M | — | View → |
| May 5, 2026 | May 5 8:31 PM | SUNG LEE | Proposed Sale | 23,906 | $66.05 | $1.6M | — | View → |
| May 5, 2026 | May 5 8:20 PM | Wendell WierengaDirector | Sale | 4,032 | $75.00 | $302.4K | 32,637(D) | View → |
| May 5, 2026 | May 5 8:18 PM | Sung LeeEVP, Chief Financial Officer | Sale | 23,906 | $76.87 | $1.8M | 63,221(D) | View → |
| May 5, 2026 | May 5 8:15 PM | John T HendersonDirector | Sale | 20,000 | $75.97 | $1.5M | 75,237(D) | View → |
| May 5, 2026 | May 5 8:11 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 11,333 | $77.25 | $875.5K | 58,555(D) | View → |
| May 1, 2026 | May 4 8:01 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 15,857 | $65.00 | $1.0M | 58,555(D) | View → |
| Apr 30, 2026 | Apr 30 8:22 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 15,000 | $63.26 | $948.9K | 58,555(D) | View → |
| Apr 29, 2026 | Apr 29 8:23 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $59.62 | $447.1K | 407,830(D) | View → |
| Apr 21, 2026 | Apr 21 8:22 PM | Fady Ibraham MalikEVP Research & Development | Sale | 3,500 | $65.69 | $229.9K | 153,902(D) | View → |
| Apr 15, 2026 | Apr 15 9:29 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 7,449 | $66.02 | $491.8K | 58,555(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | May 27 11:08 PM | Wendell WierengaDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:07 PM | Nancy WysenskiDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 19, 2026 | May 20 8:00 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 3,500 | $7.80 | 47,886(D) | View → |
| May 5, 2026 | May 5 9:35 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 3,500 | $7.80 | 51,386(D) | View → |
| May 5, 2026 | May 5 8:20 PM | Wendell WierengaDirector | Option Exercise | 4,032 | $12.40 | 0(D) | View → |
| May 5, 2026 | May 5 8:15 PM | John T HendersonDirector | Option Exercise | 20,000 | $7.61 | 0(D) | View → |
| May 5, 2026 | May 5 8:11 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 11,333 | $39.13 | 13,070(D) | View → |
| May 1, 2026 | May 4 8:01 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 15,857 | $37.63 | 0(D) | View → |
| Apr 30, 2026 | Apr 30 8:22 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 15,000 | $23.26 | 54,000(D) | View → |
| Apr 21, 2026 | Apr 21 8:22 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 3,500 | $7.80 | 54,886(D) | View → |
| Apr 7, 2026 | Apr 8 8:18 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 4,500 | $10.60 | 0(D) | View → |
| Mar 15, 2026 | Mar 17 8:11 PM | Robert I BlumDirector, President & CEO | Grant/Award | 113,529 | $60.06 | 111,864(D) | View → |
| Mar 15, 2026 | Mar 17 8:08 PM | Andrew CallosEVP, Chief Commercial Officer | Grant/Award | 31,145 | $60.06 | 29,480(D) | View → |
| Mar 15, 2026 | Mar 17 8:06 PM | Jeffrey HessekielChief Legal & Admin Officer | Grant/Award | 31,145 | $60.06 | 22,820(D) | View → |
| Mar 15, 2026 | Mar 17 8:05 PM | Sung LeeEVP, Chief Financial Officer | Grant/Award | 31,145 | $60.06 | 29,480(D) | View → |
| Mar 15, 2026 | Mar 17 8:03 PM | Fady Ibraham MalikEVP Research & Development | Grant/Award | 41,192 | $60.06 | 39,527(D) | View → |
| Mar 5, 2026 | Mar 5 9:27 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 26,000 | $39.13 | 69,000(D) | View → |
| Mar 2, 2026 | Mar 2 9:28 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 886 | $37.63 | 0(D) | View → |
| Feb 5, 2026 | Feb 6 1:17 AM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 15,000 | $23.26 | 84,000(D) | View → |
| Feb 2, 2026 | Feb 2 9:40 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 886 | $37.63 | 886(D) | View → |
← Previous
Page 2 of 2